ロード中...
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy
BACKGROUND: Cerebral palsy (CP) is the most common cause of physical disabilities in children in high‐income countries. Spasticity is the most common motor disturbance in CP. Botulinum toxin type A (BoNT‐A) is considered the first‐line treatment for focal spasticity in people with CP. OBJECTIVES: To...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2019
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779591/ https://ncbi.nlm.nih.gov/pubmed/31591703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001408.pub2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|